Elismetrep Clinical Trials (2026): 3 Studies for Acute Migraine & Migraine

Where to Participate: All Elismetrep Trial Sites in the U.S. (146 sites across 34 states)

Every actively recruiting Elismetreptrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Elismetrep clinical trials at a glance: phase × recruitment status

Recruiting Elismetrep clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Elismetrep clinical trials by indication

Elismetrep pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Elismetrep trials (3)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Elismetrep clinical trials: frequently asked questions

How many Elismetrep clinical trials are there?

3 Elismetrep clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 1 is marked completed.

Are Elismetrep clinical trials recruiting in 2026?

Yes — 2 Elismetrep trials are actively recruiting in 2026, with 146 U.S. sites across 34 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Elismetrep being studied for?

Elismetrep is being studied for Acute Migraine, Migraine. The trials are grouped by indication on this page.

What phase is Elismetrep in?

Elismetrep clinical trials span 2 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Elismetrep clinical trials?

The lead sponsor across the most Elismetrep trials is Kallyope Inc.. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Elismetrepas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed August 27, 2026.